Annual FCF
$842.00 M
-$200.00 M-19.19%
31 December 2023
Summary:
Teva Pharmaceutical Industries Limited annual free cash flow is currently $842.00 million, with the most recent change of -$200.00 million (-19.19%) on 31 December 2023. During the last 3 years, it has risen by +$204.00 million (+31.97%). TEVA annual FCF is now -82.35% below its all-time high of $4.77 billion, reached on 31 December 2015.TEVA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$545.00 M
+$539.00 M+8983.33%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited quarterly free cash flow is currently $545.00 million, with the most recent change of +$539.00 million (+8983.33%) on 30 September 2024. Over the past year, it has increased by +$689.00 million (+478.47%). TEVA quarterly FCF is now -62.47% below its all-time high of $1.45 billion, reached on 31 December 2014.TEVA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$1.37 B
+$689.00 M+101.47%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited TTM free cash flow is currently $1.37 billion, with the most recent change of +$689.00 million (+101.47%) on 30 September 2024. Over the past year, it has increased by +$760.00 million (+125.00%). TEVA TTM FCF is now -73.41% below its all-time high of $5.14 billion, reached on 30 June 2015.TEVA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TEVA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.2% | +478.5% | +125.0% |
| 3 y3 years | +32.0% | +42.3% | +1454.5% |
| 5 y5 years | -53.1% | +249.4% | +3357.1% |
TEVA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -19.2% | +256.8% | -48.8% | +291.9% | at high | +1454.5% |
| 5 y | 5 years | -53.1% | +277.6% | -48.8% | +198.2% | at high | +1144.3% |
| alltime | all time | -82.3% | +692.5% | -62.5% | +198.2% | -73.4% | +1144.3% |
Teva Pharmaceutical Industries Limited Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $545.00 M(+8983.3%) | $1.37 B(+101.5%) |
| June 2024 | - | $6.00 M(-102.4%) | $679.00 M(-22.7%) |
| Mar 2024 | - | -$248.00 M(-123.3%) | $878.00 M(+4.3%) |
| Dec 2023 | $842.00 M(-19.2%) | $1.06 B(-839.6%) | $842.00 M(+38.5%) |
| Sept 2023 | - | -$144.00 M(-170.2%) | $608.00 M(-48.2%) |
| June 2023 | - | $205.00 M(-172.2%) | $1.17 B(+21.7%) |
| Mar 2023 | - | -$284.00 M(-134.2%) | $964.00 M(-7.5%) |
| Dec 2022 | $1.04 B(+341.5%) | $831.00 M(+97.4%) | $1.04 B(+102.7%) |
| Sept 2022 | - | $421.00 M(<-9900.0%) | $514.00 M(+8.0%) |
| June 2022 | - | -$4.00 M(-98.1%) | $476.00 M(-18.6%) |
| Mar 2022 | - | -$206.00 M(-168.0%) | $585.00 M(+147.9%) |
| Dec 2021 | $236.00 M(-63.0%) | $303.00 M(-20.9%) | $236.00 M(+168.2%) |
| Sept 2021 | - | $383.00 M(+264.8%) | $88.00 M(-167.2%) |
| June 2021 | - | $105.00 M(-118.9%) | -$131.00 M(+39.4%) |
| Mar 2021 | - | -$555.00 M(-458.1%) | -$94.00 M(-114.7%) |
| Dec 2020 | $638.00 M(+186.1%) | $155.00 M(-5.5%) | $638.00 M(-29.3%) |
| Sept 2020 | - | $164.00 M(+15.5%) | $902.00 M(+0.9%) |
| June 2020 | - | $142.00 M(-19.8%) | $894.00 M(+116.5%) |
| Mar 2020 | - | $177.00 M(-57.8%) | $413.00 M(+85.2%) |
| Dec 2019 | $223.00 M(-87.6%) | $419.00 M(+168.6%) | $223.00 M(-631.0%) |
| Sept 2019 | - | $156.00 M(-146.0%) | -$42.00 M(-150.0%) |
| June 2019 | - | -$339.00 M(+2507.7%) | $84.00 M(-81.3%) |
| Mar 2019 | - | -$13.00 M(-108.4%) | $449.00 M(-75.0%) |
| Dec 2018 | $1.79 B(+32.9%) | $154.00 M(-45.4%) | $1.79 B(-19.6%) |
| Sept 2018 | - | $282.00 M(+984.6%) | $2.23 B(-11.9%) |
| June 2018 | - | $26.00 M(-98.0%) | $2.53 B(-7.9%) |
| Mar 2018 | - | $1.33 B(+125.2%) | $2.75 B(+103.6%) |
| Dec 2017 | $1.35 B(-54.8%) | $592.00 M(+1.5%) | $1.35 B(+161.8%) |
| Sept 2017 | - | $583.00 M(+140.9%) | $516.00 M(-56.0%) |
| June 2017 | - | $242.00 M(-466.7%) | $1.17 B(-31.8%) |
| Mar 2017 | - | -$66.00 M(-72.8%) | $1.72 B(-42.5%) |
| Dec 2016 | $2.99 B(-37.3%) | -$243.00 M(-119.6%) | $2.99 B(-35.0%) |
| Sept 2016 | - | $1.24 B(+57.4%) | $4.60 B(+7.4%) |
| June 2016 | - | $788.00 M(-34.6%) | $4.28 B(-10.9%) |
| Mar 2016 | - | $1.20 B(-11.9%) | $4.80 B(+0.7%) |
| Dec 2015 | $4.77 B(+13.6%) | $1.37 B(+48.1%) | $4.77 B(-1.8%) |
| Sept 2015 | - | $923.00 M(-29.6%) | $4.86 B(-5.6%) |
| June 2015 | - | $1.31 B(+12.1%) | $5.14 B(+9.6%) |
| Mar 2015 | - | $1.17 B(-19.5%) | $4.69 B(+11.8%) |
| Dec 2014 | $4.20 B(+90.3%) | $1.45 B(+19.8%) | $4.20 B(+29.2%) |
| Sept 2014 | - | $1.21 B(+40.8%) | $3.25 B(+44.2%) |
| June 2014 | - | $861.00 M(+27.9%) | $2.25 B(+10.3%) |
| Mar 2014 | - | $673.00 M(+34.1%) | $2.04 B(-7.5%) |
| Dec 2013 | $2.21 B(-36.4%) | $502.00 M(+132.4%) | $2.21 B(-25.3%) |
| Sept 2013 | - | $216.00 M(-66.8%) | $2.95 B(-16.5%) |
| June 2013 | - | $650.00 M(-22.4%) | $3.54 B(-7.5%) |
| Mar 2013 | - | $838.00 M(-33.0%) | $3.82 B(+10.3%) |
| Dec 2012 | $3.47 B(+12.6%) | $1.25 B(+56.4%) | $3.47 B(+4.2%) |
| Sept 2012 | - | $799.00 M(-14.7%) | $3.33 B(+21.7%) |
| June 2012 | - | $937.00 M(+94.4%) | $2.74 B(-5.6%) |
| Mar 2012 | - | $482.00 M(-56.6%) | $2.90 B(-6.0%) |
| Dec 2011 | $3.08 B | $1.11 B(+439.3%) | $3.08 B(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $206.00 M(-81.2%) | $2.84 B(-22.3%) |
| June 2011 | - | $1.10 B(+64.9%) | $3.65 B(+8.3%) |
| Mar 2011 | - | $666.00 M(-23.3%) | $3.37 B(-1.6%) |
| Dec 2010 | $3.43 B(+29.1%) | $868.00 M(-14.8%) | $3.43 B(+3.7%) |
| Sept 2010 | - | $1.02 B(+24.6%) | $3.30 B(+6.1%) |
| June 2010 | - | $818.00 M(+13.5%) | $3.11 B(+17.8%) |
| Mar 2010 | - | $721.00 M(-3.2%) | $2.64 B(-0.5%) |
| Dec 2009 | $2.65 B(+4.1%) | $745.00 M(-10.1%) | $2.65 B(-1.6%) |
| Sept 2009 | - | $829.00 M(+138.9%) | $2.70 B(+12.4%) |
| June 2009 | - | $347.00 M(-52.7%) | $2.40 B(-10.4%) |
| Mar 2009 | - | $733.00 M(-7.0%) | $2.68 B(+5.1%) |
| Dec 2008 | $2.55 B(+100.6%) | $788.00 M(+48.1%) | $2.55 B(+18.1%) |
| Sept 2008 | - | $532.00 M(-15.0%) | $2.16 B(+17.9%) |
| June 2008 | - | $626.00 M(+3.6%) | $1.83 B(+19.5%) |
| Mar 2008 | - | $604.00 M(+52.1%) | $1.53 B(+20.5%) |
| Dec 2007 | $1.27 B(-23.8%) | $397.00 M(+94.6%) | $1.27 B(-16.4%) |
| Sept 2007 | - | $204.00 M(-37.6%) | $1.52 B(-24.4%) |
| June 2007 | - | $327.00 M(-4.7%) | $2.01 B(+12.1%) |
| Mar 2007 | - | $343.00 M(-46.9%) | $1.79 B(+7.6%) |
| Dec 2006 | $1.67 B(+57.4%) | $646.50 M(-7.0%) | $1.67 B(+39.3%) |
| Sept 2006 | - | $695.10 M(+529.6%) | $1.20 B(+48.8%) |
| June 2006 | - | $110.40 M(-48.9%) | $804.50 M(-23.4%) |
| Mar 2006 | - | $216.00 M(+22.8%) | $1.05 B(-0.9%) |
| Dec 2005 | $1.06 B(+13.4%) | $175.90 M(-41.8%) | $1.06 B(-9.3%) |
| Sept 2005 | - | $302.20 M(-15.2%) | $1.17 B(-1.2%) |
| June 2005 | - | $356.50 M(+58.2%) | $1.18 B(+18.2%) |
| Mar 2005 | - | $225.40 M(-20.8%) | $1.00 B(+7.0%) |
| Dec 2004 | $935.00 M(+123.1%) | $284.70 M(-10.0%) | $935.00 M(+21.1%) |
| Sept 2004 | - | $316.40 M(+81.5%) | $771.80 M(+44.0%) |
| June 2004 | - | $174.30 M(+9.2%) | $535.90 M(+30.1%) |
| Mar 2004 | - | $159.60 M(+31.4%) | $412.00 M(-1.7%) |
| Dec 2003 | $419.10 M(+116.8%) | $121.50 M(+50.9%) | $419.10 M(+52.2%) |
| Sept 2003 | - | $80.50 M(+59.7%) | $275.40 M(+8.1%) |
| June 2003 | - | $50.40 M(-69.8%) | $254.70 M(-10.9%) |
| Mar 2003 | - | $166.70 M(-850.9%) | $286.00 M(+48.0%) |
| Dec 2002 | $193.30 M(+39.0%) | -$22.20 M(-137.1%) | $193.30 M(-13.2%) |
| Sept 2002 | - | $59.80 M(-26.8%) | $222.78 M(+12.6%) |
| June 2002 | - | $81.70 M(+10.4%) | $197.82 M(+32.3%) |
| Mar 2002 | - | $74.00 M(+916.2%) | $149.49 M(+7.5%) |
| Dec 2001 | $139.08 M(+82.5%) | $7.28 M(-79.1%) | $139.08 M(+5.5%) |
| Sept 2001 | - | $34.84 M(+4.4%) | $131.80 M(+35.9%) |
| June 2001 | - | $33.38 M(-47.5%) | $96.96 M(+52.5%) |
| Mar 2001 | - | $63.59 M | $63.59 M |
| Dec 2000 | $76.21 M(-13.4%) | - | - |
| Dec 1999 | $87.98 M(+396.1%) | - | - |
| Dec 1998 | $17.74 M(-86.4%) | - | - |
| Dec 1997 | $130.20 M(-191.6%) | - | - |
| Dec 1996 | -$142.10 M(+822.7%) | - | - |
| Dec 1995 | -$15.40 M(-65.3%) | - | - |
| Dec 1994 | -$44.40 M(+398.9%) | - | - |
| Dec 1993 | -$8.90 M(-60.1%) | - | - |
| Dec 1992 | -$22.30 M(+68.9%) | - | - |
| Dec 1991 | -$13.20 M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual free cash flow?
- What is the all time high annual FCF for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual FCF year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly free cash flow?
- What is the all time high quarterly FCF for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly FCF year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM free cash flow?
- What is the all time high TTM FCF for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM FCF year-on-year change?
What is Teva Pharmaceutical Industries Limited annual free cash flow?
The current annual FCF of TEVA is $842.00 M
What is the all time high annual FCF for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual free cash flow is $4.77 B
What is Teva Pharmaceutical Industries Limited annual FCF year-on-year change?
Over the past year, TEVA annual free cash flow has changed by -$200.00 M (-19.19%)
What is Teva Pharmaceutical Industries Limited quarterly free cash flow?
The current quarterly FCF of TEVA is $545.00 M
What is the all time high quarterly FCF for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly free cash flow is $1.45 B
What is Teva Pharmaceutical Industries Limited quarterly FCF year-on-year change?
Over the past year, TEVA quarterly free cash flow has changed by +$689.00 M (+478.47%)
What is Teva Pharmaceutical Industries Limited TTM free cash flow?
The current TTM FCF of TEVA is $1.37 B
What is the all time high TTM FCF for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM free cash flow is $5.14 B
What is Teva Pharmaceutical Industries Limited TTM FCF year-on-year change?
Over the past year, TEVA TTM free cash flow has changed by +$760.00 M (+125.00%)